Diabetes mellitus (DM) is a chronic systemic disease that has increases in prevalence over
time. DM can affect all ocular structures, with cataract being the most common ocular …

The management of diabetic retinopathy (DR) has evolved considerably over the past
decade, with the availability of new technologies (diagnostic and therapeutic). As such, the …

India is considered the diabetes capital of the world, and a significant proportion of patients
undergoing cataract surgery are diabetic. Considering this, we reviewed the principles and …

PURPOSE: To determine the incidence of diabetic retinopathy (DR) progression after
phacoemulsification in patients with type II diabetes. SETTING: Service of Ophthalmology …

Purpose: To evaluate whether intravitreal ranibizumab injection at cataract surgery prevents
postoperative diabetic macular edema (PME) in patients with stable diabetic retinopathy …

Purpose Diabetic macular oedema (DMO) is a leading cause of blindness in working-age
adults. Slow-release, nonbioerodible fluocinolone acetonide (FAc) implants have shown …

PURPOSE: To evaluate the role of intravitreal bevacizumab, an anti-vascular endothelial
growth factor agent, injected at the time of cataract surgery on the postoperative progression …

Purpose To determine the potential role of intraoperative dexamethasone intravitreal implant
(DEX-I) in reducing diabetic macular edema (DME) worsening after phacoemulsification …

PURPOSE: To examine the factors affecting visual outcome after phacoemulsification and
evaluate the use of preoperative visual potential in assessing the visual prognosis in …

Background Patients with pre-existing macular edema (ME) due to diabetes and retinal vein
occlusions (RVO) make up a growing population receiving cataract surgery. Surgery is …